Ozempic (semaglutide) is a once-weekly GLP-1 receptor agonist used for type 2 diabetes mellitus in the UK
Harnessing the therapeutic potential of hepatokines and addressing metabolic dysfunction may not only decelerate AD progression but also transform paradigms in neurodegenerative disease management
The FDA has established classifications for ~1700 different generic types of devices, grouped into 16 medical specialties known as device classification panels 4
Body composition matters more than the number on the scale
However, additional studies are needed for confirmation in models outside of our MUN model
Whether you use Zealthy Legit, PlexusDx, or another provider, the combination of thorough clinical screening, transparent pharmacy sourcing, and optional genetic context creates the strongest foundation for safe, evidence-based GLP-1 care